Results 51 to 60 of about 30,919 (277)

Glycosuria amount in response to hyperglycaemia and risk for diabetic kidney disease and related events in Type 1 diabetic patients.

open access: yesNephrology, Dialysis and Transplantation, 2018
Background Hyperglycaemia impairs tubulo-glomerular feedback. We tested whether variable tubulo-glomerular feedback during hyperglycaemia contributes to renal risk heterogeneity seen in Type 1 diabetes. Methods During the period 1990-92, we studied the
C. Carpentier   +12 more
semanticscholar   +1 more source

Biosynthesis of H2S is impaired in non-obese diabetic (NOD) mice [PDF]

open access: yes, 2008
Hydrogen sulphide (H2S) has been involved in cardiovascular homoeostasis but data about its role in animal models of diabetic pathology are still lacking.
Brancaleone V   +5 more
core   +1 more source

Long‐Term Effects of Sglt2 Deletion on Bone and Mineral Metabolism in Mice

open access: yesJBMR Plus, 2021
Sodium‐glucose cotransporter 2 (SGLT2) inhibitors improve kidney and cardiovascular outcomes in patients with type 2 diabetes mellitus (T2DM). However, bone fragility has emerged as a side effect in some but not in all human studies. Because use of SGLT2
Claire Gerber   +5 more
doaj   +1 more source

Serum uric acid and disorders of glucose metabolism: the role of glycosuria

open access: yesBrazilian Journal of Medical and Biological Research, 2014
Hyperuricemia has been associated with hypertension, diabetes mellitus, and metabolic syndrome. We studied the association between hyperuricemia and glycemic status in a nonrandomized sample of primary care patients.
J.A.M. Andrade   +4 more
doaj   +1 more source

The effect of Eck and reverse Eck fistula in dogs with experimental diabetes mellitus [PDF]

open access: yes, 1959
1. 1. Dogs with alloxan diabetes were subjected to Eck fistula. This procedure produced a marked increase in the amount of insulin necessary to control glycosuria.
Meyer, WH, Starzl, TE
core  

Dietary patterns and risk factors for Type 2 diabetes mellitus in Fijian, Japanese and Vietnamese populations [PDF]

open access: yes, 2002
Diabetes mellitus is now a serious and increasing problem in Asian countries, where dietary patterns have shifted toward Westernized foods and people are becoming more sedentary.
Anh, Nguyen Thi Lan   +6 more
core   +1 more source

Cytosolic Phosphoenoylpyruvate Carboxykinase Deficiency: Clinical, Biochemical, and Genetic Features of Five Non‐Finnish Patients

open access: yesAmerican Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Cytosolic phosphoenoylpyruvate carboxykinase (PEPCK‐C) is an essential, rate‐limiting enzyme in the gluconeogenesis pathway. PEPCK‐C deficiency presents with hypoglycaemia, hyperlactataemia and hepatopathy, and was first reported in association with bi‐allelic PCK1 variants in 2014.
Isaac Bernhardt   +9 more
wiley   +1 more source

Using molecular rotors to probe gelation [PDF]

open access: yes, 2015
A series of fluorescent probes, including a number of molecular rotors, have been used to follow the self-assembly of dipeptide-based low molecular weight gelators.
Adams, Dave J.   +6 more
core   +5 more sources

Diabetes Mellitus ve Obezite Hastalarında Üriner Sistem Enfeksiyonu: Geriye Dönük Değerlendirme

open access: yesDüzce Tıp Fakültesi Dergisi, 2018
Amaç: Bu çalışmada, hastanemiz erişkin ve çocuk endokrin polikliniklerinde diabetes mellitus (DM) ve obezite tanısı almış hastalarda, üriner sistem enfeksiyon etkeni olarak izole edilen patojenlerin dağılımı, bu patojenlerin antimikrobiyallere direnç ...
Özge KILINÇEL   +5 more
doaj   +1 more source

Efficacy and safety of empagliflozin for treating neutropenia and neutrophil dysfunction in paediatric patients with glycogen storage disease type Ib: A systematic review and meta‐analysis

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Glycogen storage disease type Ib (GSD‐Ib) is a rare genetic disorder causing neutropenia and neutrophil dysfunction in children. G‐CSF has been the primary treatment, but emerging data support the potential of empagliflozin, an SGLT2 inhibitor, as a promising investigational option.
Elizabeth Iwasyk   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy